Congress And Regulators Slow To Respond To Drug Pricing And Shortage Problem | Latest News RSS feed Jetpack

Congress And Regulators Slow To Respond To Drug Pricing And Shortage Problem - Latest News

Congress and regulators slow to respond to drug pricing and shortage problem

The views expressed by contributors are their own and not the view of The Hill Hospitals, doctors, and their patients are confronting two related drug access problems that should be unimaginable in American society: a shortage of essential medicines and ... read more

CONGRESSMAN: Price hikes for drugs are 'like putting a gun to somebody's head'

In a telephone call, Cummings spoke with Business Insider about what drew him to the issue of price ... a problem that we must solve as a Congress, and we cannot remain silent." He has no plans to let Congress ease up on the pressure it's putting on drug ... read more

Drugmaker under fire for taxpayer-funded cancer drug that costs $129,269 a year

Despite its considerable power, the National Institutes of Health has declined five petitions requesting its march-in rights be used as an antidote to high drug prices or shortage problems ... the letter from Congress and would respond. read more

Looking for another news?

The solutions to America's drug cost dilemma (and why they won't happen)

Congress has been grilling drug company executives over their big price hikes. Democratic presidential nominee ... He served as managing editor of Modern Healthcare from 2013 to 2015. His more than three decades of journalism experience includes freelance ... read more

Drug shortages hit an all-time high

The only problem? Doxil wasn’t available. It is one of the drugs on the drug shortage ... or price gouging in these essential drug markets.” President Obama did sign an executive order this past October requiring the FDA to expedite regulatory reviews ... read more

Pharma lobby 'fighting back' on drug prices

A top pharmaceutical lobbying group will begin a counteroffensive against scrutiny of industry pricing practices, responding to ... were lambasted by Congress this year for their practice of sharply raising prices on older drugs, and investors are urging ... read more

Overnight Health Care — Sponsored by PCMA — New details on Trump's drug pricing plan

New details on Trump's drug pricing plan. Secretary of Health and Human Services ... Azar didn't have a definitive answer when he was asked what drugs could shift, but the list could be substantial. The idea is sure to get major opposition from drug ... read more

FDA partly to blame in EpiPen price debacle

A major problem ... drugs already sold in countries with regulatory systems comparable to our own." The FDA already eases approval of some imports if it is to alleviate a drug shortage. Little to nothing has been done in Congress on drug prices, despite ... read more

President Trump: Competition Is the Solution to High Drug Prices

The Food and Drug Administration (FDA) approval process is currently too slow, too costly, and too precautionary. This induces caution in drug companies, who constrict their development pipelines to less risky "sure thing" therapies. The high regulatory ... read more

Pharma group punches back on drug prices as pressure rises

It was in response to a new charge related to the securities fraud case... "I worry that we take progress for granted and investors can move to places with less regulatory ... Congress this year for their practice of sharply raising prices on older drugs ... read more

FeedsRSS Created by. Full RSS Feed | Privacy Policy | Contact Us